Learning from COVID-19 to reimagine tuberculosis diagnosis
- PMID: 33778790
- PMCID: PMC7979141
- DOI: 10.1016/S2666-5247(21)00057-4
Learning from COVID-19 to reimagine tuberculosis diagnosis
Conflict of interest statement
MR and SC are employees of Foundation of Innovative New Diagnostics (FIND). MP is an advisor to FIND. FIND is a not-for-profit foundation that supports the development, evaluation, and implementation of several diagnostics, including tuberculosis and COVID-19. FIND has product evaluation agreements with several private sector companies that design diagnostics for global health. These agreements strictly define FIND's independence and neutrality regarding the companies whose products get evaluated and describe roles and responsibilities. FIND is co-convener of the Access to COVID-19 Tools Accelerator, a partnership to accelerate access to the diagnostics tools needed in the COVID-19 response.
References
-
- Pai M. Tuberculosis and COVID-19: fighting a deadly syndemic. Sept 26, 2020. https://www.forbes.com/sites/madhukarpai/2020/09/26/tuberculosis-and-cov...
-
- Budd J, Miller BS, Manning EM. Digital technologies in the public-health response to COVID-19. Nat Med. 2020;26:1183–1192. - PubMed
-
- Williams C, Pan DD, Decker J. COVID-19: exhaled virus detected by face-mask sampling provides new links to disease severity and potential infectivity. medRxiv. 2020 https://www.medrxiv.org/content/10.1101/2020.08.18.20176693v1 published online Aug 21. (preprint). - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
